These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37129293)

  • 1. Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections.
    Kong FYS; Kenyon C; Unemo M
    J Antimicrob Chemother; 2023 Jul; 78(7):1561-1568. PubMed ID: 37129293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
    Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L;
    Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Vanbaelen T; Tsoumanis A; Kenyon C
    Clin Infect Dis; 2024 Mar; 78(3):803-805. PubMed ID: 37721151
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical Considerations in Implementing Doxycycline Postexposure Prophylaxis for the Prevention of Bacterial Sexually Transmitted Infections.
    Sugarman J; Taylor HA; Bachmann LH; Barbee LA; Cahill S; Celum C; Cohen SE; Faden RR; Luetkemeyer AF; Mayer KH; Mena L; Mermin J; Upshur R; Aral S
    Sex Transm Dis; 2024 Mar; 51(3):135-138. PubMed ID: 38079243
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
    Grant JS; Stafylis C; Celum C; Grennan T; Haire B; Kaldor J; Luetkemeyer AF; Saunders JM; Molina JM; Klausner JD
    Clin Infect Dis; 2020 Mar; 70(6):1247-1253. PubMed ID: 31504345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).
    Cornelisse VJ; Ong JJ; Ryder N; Ooi C; Wong A; Kenchington P; Giola M; Donovan B; Dean JA; Molina JM; Medland NA
    Sex Health; 2023 Apr; 20(2):99-104. PubMed ID: 36927481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline Postexposure Prophylaxis for STIs in Women - Uncertain Benefit, Urgent Need.
    Marrazzo J
    N Engl J Med; 2023 Dec; 389(25):2389-2390. PubMed ID: 38118030
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics.
    Pearson WS; Emerson B; Hogben M; Barbee L
    Emerg Infect Dis; 2024 Jan; 30(1):197-199. PubMed ID: 38147529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence on "A case for the inclusion of doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men in sub-Saharan African countries' guidelines for the management of sexually transmitted infections" by "Dzinamarira
    Dzinamarira T; Moyo E; Murewanhema G
    Sex Transm Infect; 2024 Jan; 100(1):57. PubMed ID: 37833057
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils.
    Siguier M; Molina JM
    ACS Infect Dis; 2018 May; 4(5):660-663. PubMed ID: 29570279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa.
    Peters RPH; McIntyre JA; Garrett N; Brink AJ; Celum CL; Bekker LG
    South Afr J HIV Med; 2023; 24(1):1510. PubMed ID: 37795430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections.
    Cannon CA; Celum CL
    Top Antivir Med; 2023 Dec; 31(5):566-575. PubMed ID: 38198668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.
    Spinelli MA; Scott HM; Vittinghoff E; Liu AY; Coleman K; Buchbinder SP
    Sex Transm Dis; 2019 Apr; 46(4):e32-e34. PubMed ID: 30870327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area.
    Mårdh O; Plachouras D
    Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971658
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections.
    Williams E; Fairley CK; Williamson D
    Curr Opin Infect Dis; 2021 Dec; 34(6):591-598. PubMed ID: 34545855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline PEP for prevention of STIs.
    Venkatesan P
    Lancet Infect Dis; 2022 Nov; 22(11):1545. PubMed ID: 36309026
    [No Abstract]   [Full Text] [Related]  

  • 18. Sexually Transmitted Infection Review for the Acute Care Pharmacist.
    Mah ND; Birmingham AR; Treu CN; Bodkin RP; Awad NI; Acquisto NM
    J Pharm Pract; 2020 Feb; 33(1):63-73. PubMed ID: 29558852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?
    Kenyon C; Van Dijck C; Florence E
    Curr Opin Infect Dis; 2020 Feb; 33(1):51-58. PubMed ID: 31789694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually Transmitted Infections.
    McCormack D; Koons K
    Emerg Med Clin North Am; 2019 Nov; 37(4):725-738. PubMed ID: 31563204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.